Draft Guidance for Industry on Good Importer Practices; Availability, 1692-1693 [E9-453]

Download as PDF 1692 Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices Committee Name Advisory Committee 10-Digit Information Line Code Tentative Date of Meeting(s) Anesthesiology and Respiratory Therapy Devices Panel February 5, April 30, July 23, September 17, November 12 3014512624 Circulatory System Devices Panel February 25, May 27, September 24 3014512625 Clinical Chemistry and Clinical Toxicology Devices Panel March 18–19, June 17–18, October 21–22 3014512514 Dental Products Panel February 11, May 6, June 17, September 16, December 9 3014512518 Ear, Nose, and Throat Devices Panel February 24, May 19, August 18, November 17 3014512522 Gastroenterology-Urology Devices Panel March 20, October 15 3014512523 General and Plastic Surgery Devices Panel February 26–27, June 9–10, October 15–16 3014512519 General Hospital and Personal Use Devices Panel March 25–26, July 29–30, October 21–22 3014512520 Hematology and Pathology Devices Panel April 24, July 17, October 23 3014512515 Immunology Devices Panel October 15–16 3014512516 Medical Devices Dispute Resolution Panel Meetings occur as needed 3014510232 Microbiology Devices Panel February 24–25, September 22–23, October 27–28 3014512517 Molecular and Clinical Genetics Panel April 15, October 5–6 3014510231 Neurological Devices Panel February 26–27, May 14–15, September 17–18, December 2–3 3014512513 Obstetrics and Gynecology Devices Panel February 5–6, May 14–15, August 13–14, November 12– 13 3014512524 Ophthalmic Devices Panel February 12–13, May 14–15, September 24–25,November 19–20 3014512396 Orthopaedic and Rehabilitation Devices Panel February 3–4, April 14–15, June 9–10, August 11–12, October 15–16, December 1–2 3014512521 Radiological Devices Panel February 18, May 12, August 4, November 17 3014512526 National Mammography Quality Assurance Advisory Committee November 4–5 3014512397 Technical Electronic Product Radiation Safety Standards Committee No meeting tentatively scheduled for 2009 3014512399 CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee May 20–21 3014510564 CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee April 14 3014512548 NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR) Science Advisory Board to NCTR November 17–18 3014512559 Dated: December 24, 2008. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E9–451 Filed 1–12–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–01–S [Docket No. FDA–2009–D–0675] Food and Drug Administration Draft Guidance for Industry on Good Importer Practices; Availability AGENCY: Food and Drug Administration, HHS. ACTION: VerDate Nov<24>2008 19:10 Jan 12, 2009 Jkt 217001 PO 00000 Notice. Frm 00031 Fmt 4703 Sfmt 4703 SUMMARY: The Food and Drug Administration (FDA) is announcing on behalf of several members of the Interagency Working Group on Import Safety (agencies) the availability of a draft guidance for industry entitled ‘‘Good Importer Practices.’’ This draft guidance document provides general recommendations to importers on possible practices and procedures they may follow to increase the likelihood the products they import are in E:\FR\FM\13JAN1.SGM 13JAN1 Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices compliance with applicable U.S. safety and security requirements. The recommendations provided here are intended to promote and facilitate an assessment by importers of a product’s life cycle so the importer may make sound decisions about how best to address the product’s potential to cause harm and to facilitate compliance with U.S. requirements. DATES: Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the agencies consider your comments on this draft guidance before they begin work on the final version of the guidance, submit written or electronic comments on the draft guidance by April 13, 2009. ADDRESSES: Submit written requests for single copies of the draft guidance to the Food and Drug Administration, Office of Policy and Planning, 10903 New Hampshire Ave., White Oak Building 1, 4th Floor,Silver Spring, MD 20993. Send one self-addressed adhesive label to assist the office in processing your request.Submit written comments on the draft guidance to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to https:// www.regulations.gov. All comments should be identified with the docket number found in brackets in the heading of this document. See the SUPPLEMENTARY INFORMATION section for electronic access to the draft guidance document. FOR FURTHER INFORMATION CONTACT: Jeffrey Shuren, Food and Drug Administration, 10903 New Hampshire Avenue, White Oak Building 1, Silver Spring, MD 20993, 301–796–4840. SUPPLEMENTARY INFORMATION: I. Background FDA is announcing on behalf of the agencies1 the availability of a draft guidance for industry entitled ‘‘Good Importer Practices.’’ This draft guidance is issued in response to recommendations contained in the Action Plan for Import Safety: A Roadmap for Continual Improvement (Action Plan) issued on November 6, 2007, by the Interagency Working Group on Import Safety (Working Group) established by Executive Order 13439 1 The agencies who developed this draft guidance are the U.S. Consumer Product Safety Commission, the Department of Agriculture, the Department of Commerce, the Department of Health and Human Services (FDA), the Department of Homeland Security, the Department of Transportation, and the Environmental Protection Agency, as well as with input from the Office of the U.S. Trade Representative. VerDate Nov<24>2008 19:10 Jan 12, 2009 Jkt 217001 (see https://www.importsafety.gov/ report/actionplan.pdf). The Action Plan recommends that the Federal Government work with the importing community and other members of the public to develop Good Importer Practices and issue guidance. The Action Plan specifies that the focus of these practices should be to ensure that imported products meet U.S. standards, as well as to promote effective supplychain management. The Action Plan recommended that these practices be risk-based and provide concrete guidance to the importing community for evaluating imported products. This evaluation would be based on due diligence and preventive control principles. This guidance is intended for use by the importer that initiates or causes the entry or attempted entry of foreignsourced products into the United States or the reimportation of U.S.-made products (American goods returned) for commercial purposes to help ensure that such products are safe and comply with applicable U.S. requirements.2 At any point during the product’s life cycle, hazards can be introduced that may place consumers at risk unless appropriate preventive controls are implemented. In general, the recommendations advise the importer to know the foreign firms with whom they do business and through which the products they purchase pass, understand the products they import and their vulnerabilities, understand the hazards that may be introduced during the product life cycle, and ensure that these hazards have been properly controlled and monitored. Importers should consider instituting practices to identify and minimize risk. Importers should put into place controls for known vulnerabilities, such as to microbiological contamination or product defects, and monitor for other risks, such as counterfeiting or intentional contamination. These Good Importer Practices are broadly organized by four guiding principles. These four guiding principles are as follows: • Establishing a product safety management program • Knowing the product and applicable U.S. requirements • Verifying product and firm compliance with U.S. requirements throughout the supply chain and While this guidance document sets out principles and recommendations for helping to ensure the safety and security of imported products, the principles and the non-customs related recommendations are also applicable to helping ensure the safety and security of products that are domestically produced. 2 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 1693 product life cycle • Taking corrective and preventive action when the imported product or firm is not compliant with U.S. Requirements The guidance suggests actions the importer can take to accomplish each of these objectives. This draft guidance is being issued consistent with the Office of Management and Budget’s Final Bulletin for Agency Good Guidance Practices (No. 07–02 (M–07–07)). The draft guidance, when finalized, will represent the agencies’ current thinking on Good Importer Practices. It does not create or confer any rights for or on any person and does not operate to bind the agencies or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable U.S. statutes and regulations. II. Comments FDA is coordinating the receipt of submitted comments on behalf of the agencies. Interested persons may submit to FDA’s Division of Dockets Management (see ADDRESSES) written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at https://www.regulations.gov. III. Electronic Access Persons with access to the Internet may obtain the document at either https://www.fda.gov/oc/guidance/ goodimportpractice.html or https:// www.regulations.gov. Dated: January 8, 2009. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E9–453 Filed 1–12–09; 8:45 am] BILLING CODE 4160–01–S E:\FR\FM\13JAN1.SGM 13JAN1

Agencies

[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1692-1693]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-453]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-D-0675]


Draft Guidance for Industry on Good Importer Practices; 
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing on behalf 
of several members of the Interagency Working Group on Import Safety 
(agencies) the availability of a draft guidance for industry entitled 
``Good Importer Practices.'' This draft guidance document provides 
general recommendations to importers on possible practices and 
procedures they may follow to increase the likelihood the products they 
import are in

[[Page 1693]]

compliance with applicable U.S. safety and security requirements. The 
recommendations provided here are intended to promote and facilitate an 
assessment by importers of a product's life cycle so the importer may 
make sound decisions about how best to address the product's potential 
to cause harm and to facilitate compliance with U.S. requirements.

DATES: Although you can comment on any guidance at any time (see 21 CFR 
10.115(g)(5)), to ensure that the agencies consider your comments on 
this draft guidance before they begin work on the final version of the 
guidance, submit written or electronic comments on the draft guidance 
by April 13, 2009.

ADDRESSES: Submit written requests for single copies of the draft 
guidance to the Food and Drug Administration, Office of Policy and 
Planning, 10903 New Hampshire Ave., White Oak Building 1, 4th 
Floor,Silver Spring, MD 20993. Send one self-addressed adhesive label 
to assist the office in processing your request.Submit written comments 
on the draft guidance to the Division of Dockets Management (HFA-305), 
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, 
MD 20852. Submit electronic comments to https://www.regulations.gov. All 
comments should be identified with the docket number found in brackets 
in the heading of this document. See the SUPPLEMENTARY INFORMATION 
section for electronic access to the draft guidance document.

FOR FURTHER INFORMATION CONTACT: Jeffrey Shuren, Food and Drug 
Administration, 10903 New Hampshire Avenue, White Oak Building 1, 
Silver Spring, MD 20993, 301-796-4840.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing on behalf of the agencies\1\ the availability of 
a draft guidance for industry entitled ``Good Importer Practices.'' 
This draft guidance is issued in response to recommendations contained 
in the Action Plan for Import Safety: A Roadmap for Continual 
Improvement (Action Plan) issued on November 6, 2007, by the 
Interagency Working Group on Import Safety (Working Group) established 
by Executive Order 13439 (see https://www.importsafety.gov/report/
actionplan.pdf). The Action Plan recommends that the Federal Government 
work with the importing community and other members of the public to 
develop Good Importer Practices and issue guidance. The Action Plan 
specifies that the focus of these practices should be to ensure that 
imported products meet U.S. standards, as well as to promote effective 
supply-chain management. The Action Plan recommended that these 
practices be risk-based and provide concrete guidance to the importing 
community for evaluating imported products. This evaluation would be 
based on due diligence and preventive control principles.
---------------------------------------------------------------------------

    \1\ The agencies who developed this draft guidance are the U.S. 
Consumer Product Safety Commission, the Department of Agriculture, 
the Department of Commerce, the Department of Health and Human 
Services (FDA), the Department of Homeland Security, the Department 
of Transportation, and the Environmental Protection Agency, as well 
as with input from the Office of the U.S. Trade Representative.
---------------------------------------------------------------------------

    This guidance is intended for use by the importer that initiates or 
causes the entry or attempted entry of foreign-sourced products into 
the United States or the reimportation of U.S.-made products (American 
goods returned) for commercial purposes to help ensure that such 
products are safe and comply with applicable U.S. requirements.\2\ At 
any point during the product's life cycle, hazards can be introduced 
that may place consumers at risk unless appropriate preventive controls 
are implemented. In general, the recommendations advise the importer to 
know the foreign firms with whom they do business and through which the 
products they purchase pass, understand the products they import and 
their vulnerabilities, understand the hazards that may be introduced 
during the product life cycle, and ensure that these hazards have been 
properly controlled and monitored. Importers should consider 
instituting practices to identify and minimize risk. Importers should 
put into place controls for known vulnerabilities, such as to 
microbiological contamination or product defects, and monitor for other 
risks, such as counterfeiting or intentional contamination.
---------------------------------------------------------------------------

    \2\ While this guidance document sets out principles and 
recommendations for helping to ensure the safety and security of 
imported products, the principles and the non-customs related 
recommendations are also applicable to helping ensure the safety and 
security of products that are domestically produced.
---------------------------------------------------------------------------

    These Good Importer Practices are broadly organized by four guiding 
principles. These four guiding principles are as follows:
     Establishing a product safety management program
     Knowing the product and applicable U.S. requirements
     Verifying product and firm compliance with U.S. 
requirements throughout the supply chain and product life cycle
     Taking corrective and preventive action when the imported 
product or firm is not compliant with U.S. Requirements
The guidance suggests actions the importer can take to accomplish each 
of these objectives.
    This draft guidance is being issued consistent with the Office of 
Management and Budget's Final Bulletin for Agency Good Guidance 
Practices (No. 07-02 (M-07-07)). The draft guidance, when finalized, 
will represent the agencies' current thinking on Good Importer 
Practices. It does not create or confer any rights for or on any person 
and does not operate to bind the agencies or the public. An alternative 
approach may be used if such approach satisfies the requirements of the 
applicable U.S. statutes and regulations.

II. Comments

    FDA is coordinating the receipt of submitted comments on behalf of 
the agencies. Interested persons may submit to FDA's Division of 
Dockets Management (see ADDRESSES) written or electronic comments 
regarding this document. Submit a single copy of electronic comments or 
two paper copies of any mailed comments, except that individuals may 
submit one paper copy. Comments are to be identified with the docket 
number found in brackets in the heading of this document. Received 
comments may be seen in the Division of Dockets Management between 9 
a.m. and 4 p.m., Monday through Friday.
    Please note that on January 15, 2008, the FDA Division of Dockets 
Management Web site transitioned to the Federal Dockets Management 
System (FDMS). FDMS is a Government-wide, electronic docket management 
system. Electronic comments or submissions will be accepted by FDA only 
through FDMS at https://www.regulations.gov.

III. Electronic Access

    Persons with access to the Internet may obtain the document at 
either https://www.fda.gov/oc/guidance/goodimportpractice.html or http:/
/www.regulations.gov.

    Dated: January 8, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-453 Filed 1-12-09; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.